Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Other financing activities: 2015-2024

Historic Other financing activities for Mimedx Group (MDXG) over the last 1 years, with Mar 2024 value amounting to $1.1 million.

  • Mimedx Group's Other financing activities was N/A to $1.1 million in Q1 2024 from the same period last year, while for Mar 2024 it was $8.5 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is 2217.31% up from last year.
  • Mimedx Group's Other financing activities amounted to $1.1 million in Q1 2024, which was up 2,217.31% from -$52,000 recorded in Q4 2023.
  • In the past 5 years, Mimedx Group's Other financing activities registered a high of $6.5 million during Q3 2020, and its lowest value of -$52,000 during Q4 2023.
  • In the last 2 years, Mimedx Group's Other financing activities had a median value of $524,500 in 2023 and averaged $524,500.
  • Data for Mimedx Group's Other financing activities shows a peak YoY skyrocketed of 8,960.00% (in 2020) over the last 5 years.
  • Quarterly analysis of 3 years shows Mimedx Group's Other financing activities stood at $906,000 in 2020, then followed by -$52,000 in 2023, then followed by $1.1 million in 2024.
  • Its last three reported values are $1.1 million in Q1 2024, -$52,000 for Q4 2023, and $906,000 during Q4 2020.